• btc = $94 478.00 2 217.87 (2.40 %)

  • eth = $3 080.04 -28.08 (-0.90 %)

  • ton = $5.31 -0.12 (-2.26 %)

  • btc = $94 478.00 2 217.87 (2.40 %)

  • eth = $3 080.04 -28.08 (-0.90 %)

  • ton = $5.31 -0.12 (-2.26 %)

26 Oct, 2024
1 min time to read

Apple has been testing an app to help individuals with prediabetes better manage their blood sugar levels, according to a report from Bloomberg.

The experimental app aimed to show how lifestyle changes could impact blood sugar, helping users make choices to potentially reverse prediabetes and lower the risk of developing Type 2 diabetes.

The trial reportedly involved Apple employees who verified their prediabetic condition through blood tests and logged their blood sugar responses using third-party glucose monitoring devices, noting food intake and lifestyle factors. For example, the app would demonstrate how pairing protein with carbs could reduce blood sugar spikes.

The report notes that Apple has since paused the project to focus on other health initiatives, though findings from this testing could shape future Apple health tech developments.

As metabolic health tracking gains traction, Apple’s interest aligns with other tech firms. Dexcom and Abbott recently released CGMs (continuous glucose monitors) for prediabetics and Type 2 diabetics who don’t require insulin.

Additionally, startups like Nutrisense and Levels use CGMs to assist people in tracking how food affects their blood sugar levels.